- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 123,800 | 28.06.24 03:00:27 | -6,020 | -4,64% | 124,260 | 125,100 | 129,540 | 123,800 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 84,260 | 28.06.24 22:04:30 | +1,680 | +2,04% | 83,980 | 85,000 | 82,720 | 84,260 |
